Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis-Reference-Cited by-同舟云学术

Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis

Published:2015-02-09 Issue:3 Volume:125 Page:1174-1188
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Dasgupta Subhamoy,Putluri Nagireddy,Long Weiwen,Zhang Bin,Wang Jianghua,Kaushik Akash K.,Arnold James M.,Bhowmik Salil K.,Stashi Erin,Brennan Christine A.,Rajapakshe Kimal,Coarfa Cristian,Mitsiades Nicholas,Ittmann Michael M.,Chinnaiyan Arul M.,Sreekumar Arun,O’Malley Bert W.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

2. Cancer Cell Metabolism: One Hallmark, Many Faces

3. Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

4. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

5. Reductive carboxylation supports growth in tumour cells with defective mitochondria

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer;JCI Insight;2024-09-10

2. The role of SRC-3 in prostate cancer progression and implications for therapeutic targeting: A systematic review;Journal of Pharmacy & Pharmacognosy Research;2024-09-01

3. Steroid receptor coactivators in Treg and Th17 cell biology and function;Frontiers in Immunology;2024-04-18

4. Androgen receptor cofactors: A potential role in understanding prostate cancer;Biomedicine & Pharmacotherapy;2024-04

5. Complex I activity in hypoxia: implications for oncometabolism;Biochemical Society Transactions;2024-03-25